Sangamo and Pfizer announced their focus on translating genomic medicines using gene therapy for severe hemophilia A has shown promising results. Shares in $SGMO and $PFE reacted positively to the news.
Soliton stock volatilty has soared with daily 25% and 10% moves up and down since news on $SOLY’s proprietary Rapid Acoustic Pulse (RAP) device that uses acoustic shockwaves to dramatically accelerate the removal of tattoos, reduce cellulite and enhance existing fat removal technologies.
Melinta Therapeutics $MLNT focusing on the development and commercialization of novel antibiotics to treat serious bacterial infections presented multiple presentations at the European Congress of Clinical Microbiology Infectious Diseases (ECCMID).
Emerging leader in the development of innovative medical diagnostic products TT2 Biosystems will highlight how direct-from-whole blood innovations—the T2Bacteria, T2Candida and T2Resistance panelspositively impact patients with bloodstream infections at Infectious Diseases Conference.